Urinary Tract Infection Testing Devices Market Report 2026

Urinary Tract Infection Testing Devices Market Overview

• Urinary Tract Infection Testing Devices market size has reached to $0.66 billion in 2025 • Expected to grow to $0.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2% • Growth Driver: Growing Incidence Of Urinary Tract Infection Is Driving The Market • Market Trend: Advancements In Urinary Tract Infection Diagnostics With Innovative Point-Of-Care Testing System • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Urinary Tract Infection Testing Devices Market?

Urinary tract infection (UTI) testing devices are medical tools used to diagnose infections in the urinary system by detecting bacteria, white blood cells, or other markers in urine samples. These devices range from dipsticks and culture kits to advanced automated analyzers, providing rapid and accurate results to guide treatment decisions. The main product types of urinary tract infection testing devices are instruments, kits. Urinary tract infection testing kits offer convenience and cost-effectiveness, making them widely used in point-of-care settings and for self-testing. The various test types include urinalysis, urine cultures, susceptibility testing and are used by various end-users such as hospitals, diagnostic labs, other end users.

What Is The Urinary Tract Infection Testing Devices Market Growth Forecast?

The urinary tract infection testing devices market size is expected to see strong growth in the next few years. It will grow to $0.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to point-of-care testing expansion, AI-assisted urine analysis, growth in home diagnostics, rising antimicrobial resistance concerns, rapid diagnostic kit innovation. Major trends in the forecast period include rapid point-of-care UTI testing, automated urinalysis systems, home-based UTI testing kits, improved bacterial detection accuracy, antibiotic susceptibility screening.

What Is The Driver Of The Urinary Tract Infection Testing Devices Market?

The growing incidence of urinary tract infections (UTIs) is expected to propel the growth of the urinary tract infection testing devices market going forward. Urinary tract infections (UTIs) are infections that occur in any part of the urinary system, including the kidneys, ureters, bladder, or urethra, typically caused by bacteria, with Escherichia coli being the most common pathogen. The growing incidence of urinary tract infections (UTIs) are due to prolonged catheter use, inadequate hygiene practices, and increased antimicrobial resistance among hospitalized patients. Urinary tract infection testing devices help urinary tract infections (UTIs) patients by enabling rapid and accurate diagnosis, allowing healthcare providers to identify the causative pathogens and administer targeted treatments promptly, thereby reducing complications, improving patient outcomes, and minimizing the spread of antimicrobial resistance within healthcare settings. For instance, in March 2024, according to the University of New South Wales, an Australia-based public research university, UTIs are highly prevalent infections, with an estimated global incidence of over 400 million cases per year. Therefore, the growing incidence of urinary tract infections (UTIs) drives the urinary tract infection testing devices industry.

Key Players In The Global Urinary Tract Infection Testing Devices Market

Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMérieux SA, Bio‑Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.

Global Urinary Tract Infection Testing Devices Market Trends and Insights

Major companies operating in the urinary tract infection testing devices market are focusing on point-of-care (POC) testing devices for faster, more convenient diagnoses, improving patient outcomes. Point-of-care (POC) testing devices refer to medical diagnostic testing that is performed at or near the site of patient care, such as in a doctor's office, hospital bedside, or even at home, without the need to send samples to a laboratory. For instance, in June 2023, Sysmex Corporation, a Japan-based company that manufactures urinary tract infection testing devices launched PA-100 AST System, a Point-of-Care Testing System for the detection of antimicrobial susceptibility. The system can detect the presence or absence of bacteria and assess the effectiveness of antimicrobials within a short turnaround time. It reports the presence of growing bacteria in urine samples in approximately 10 minutes and provides susceptibility test results in under 30 minutes. This allows healthcare professionals to perform rapid testing directly from urine samples of patients suspected of having UTIs.

What Are Latest Mergers And Acquisitions In The Urinary Tract Infection Testing Devices Market?

In August 2024, Alpha Laboratories Ltd., a UK-based diagnostics and laboratory supplies company, entered a strategic partnership with Clinical Design Technologies Ltd to market and support the UTS digital closed urine testing system, aiming to revolutionize point-of-care urinalysis through faster, more accurate results and improved clinical efficiency. Clinical Design Technologies Ltd. is a UK-based medical device company, that developed the UTS (Urine Testing System) a digital closed urinalysis platform designed for rapid, point-of-care urine testing that streamlines workflows and delivers precise diagnostic data.

What Defines the Urinary Tract Infection Testing Devices Market?

The urinary tract infection (UTI) testing devices market consists of sales of urine analyzers, dipsticks, and culture systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Urinary Tract Infection Testing Devices Market Report 2026?

The urinary tract infection testing devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the urinary tract infection testing devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.